Live feed
Filing
SC 13G/A
SC 13G/A0001144204-18-007655·CymaBay Therapeutics, Inc.
Schedule 13G ownership disclosure
CYMABAY THERAPEUTICS INC
Security class unavailable · CUSIP: 23257D103
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 600,000
- Percent of class
- 1.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-007655
- Form type
- SC 13G/A
- Filer
- CymaBay Therapeutics, Inc.
- CIK
- CIK 1042074
- Filed
- Feb 13, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership